Eramet SA
SWB:ER7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eramet SA
SWB:ER7
|
FR |
|
Lobe Sciences Ltd
F:6YX0
|
CA |
|
P
|
Piaggio & C SpA
XMUN:P1I
|
IT |
|
FG Merger II Corp
NASDAQ:BXBL
|
US |
|
GreenFirst Forest Products Inc
F:IMT
|
CA |
|
T
|
Tucows Inc
TSX:TC
|
CA |
|
S
|
Sterling Bancorp
F:PVDA
|
US |
|
M
|
Multi Medika Internasional PT Tbk
IDX:MMIX
|
ID |
|
S
|
Strategie Kapital AG
DUS:S14
|
DE |
|
Smart Share Global Ltd
NASDAQ:EM
|
CN |
|
N
|
Novra Technologies Inc
F:7CV
|
CA |
|
S
|
Sosei Group Corp
F:JSS
|
JP |
Wall St Price Targets
ER7 Price Targets Summary
Eramet SA
According to Wall Street analysts, the average 1-year price target for
ER7 is 53.53 EUR with a low forecast of 43.33 EUR and a high forecast of 66 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ER7's stock price target?
Price Target
53.53
EUR
According to Wall Street analysts, the average 1-year price target for
ER7 is 53.53 EUR with a low forecast of 43.33 EUR and a high forecast of 66 EUR.
What is the Revenue forecast for Eramet SA?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 3 years is 9%.